Early Validation of a Structural Magnetic Resonance Imaging Metric for Tracking Dementia‐Related Neurodegeneration

Current research is focused on noninvasive biomarkers of neurodegeneration that can detect dementia early, benchmark disease severity, monitor disease progression, and aid in testing the efficacy of therapeutic interventions utilizing a single number1–3. The objective of this study is to create and begin to validate an intuitively meaningful biomarker called the ADNeuro‐Score.